HMOX1 and hemolytic-uremic syndrome: In order to evaluate the impact of renal HO-1 reduction on the development of HUS, we monitored the clinical presentation (HUS score, weight loss) and survival of Hmox1R26∆/∆ and Hmox1lox/lox mice for a period of 7 days.